Literature DB >> 6223066

Circulating T cell subsets in euthyroid Graves' disease.

M Bagnasco, G W Canonica, S Ferrini, G Ciprandi, W Dirienzo, G Giordano, O Ferrini.   

Abstract

T cell subpopulations recognized by surfaces markers of different functional meaning have been evaluated in 12 female patients with euthyroid Graves' disease and in 2 patients with ophthalmopathy and Hashimoto's thyroiditis. We have used the following markers: i) receptors for Fc fragments of IgG; ii) antigens recognized by the monoclonal antibodies MLR4, 5/9, BT 2/9 (anti-DR). In the 12 patients with euthyroid Graves' disease a marked decrease of TG cells (which proved to exert suppressor function in several in vitro systems) was observed, as previously reported in hyperthyroid Graves' disease. The 2 Hashimoto's patients with eye changes had normal or high TG. 5/9+ T cells (which contain cells with helper activity in vitro), as well as MLR4+ and BT 2/9+ cells (activated T cells) were normal in the majority of patients, but elevated in the 2 Hashimoto's thyroiditis. The observed abnormality of TG cells in euthyroid Graves' disease might be consistent with the hypothesized autoimmune pathogenesis of endocrine ophthalmopathy.

Entities:  

Mesh:

Year:  1983        PMID: 6223066     DOI: 10.1007/BF03350583

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  The role of autoimmunity in hypoendocrine and hyperendocrine function: with special emphasis on autoimmune thyroid disease.

Authors:  R Volpé
Journal:  Ann Intern Med       Date:  1977-07       Impact factor: 25.391

Review 2.  Characterization of human T-cell subpopulations as defined by specific receptors for immunoglobulins.

Authors:  L Moretta; M Ferrarini; M D Cooper
Journal:  Contemp Top Immunobiol       Date:  1978

3.  T lymphocyte subpopulations in Graves' disease: relationship with clinical conditions.

Authors:  M Bagnasco; G W Canonica; S Ferrini; P Biassoni; G Melioli; O Ferrini; G Giordano
Journal:  Acta Endocrinol (Copenh)       Date:  1983-02

4.  Suppressor activity of T cells bearing Fc receptors for IgG on lymphoid colony formation.

Authors:  G W Canonica; V Pistoia; R Ghio; M C Mingari; L Moretta
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

5.  Circulating T lymphocytes in Hashimoto's disease: imbalance of subsets and presence of activated cells.

Authors:  G W Canonica; M Bagnasco; G Corte; S Ferrini; O Ferrini; G Giordano
Journal:  Clin Immunol Immunopathol       Date:  1982-06

6.  Human T-lymphocyte subpopulations in Hashimoto's disease.

Authors:  G W Canonica; M Bagnasco; L Moretta; R Cocco; O Ferrini; G Giordano
Journal:  J Clin Endocrinol Metab       Date:  1981-03       Impact factor: 5.958

7.  Immune suppression of hematopoiesis in aplastic anemia: activity of T-gamma lymphocytes.

Authors:  A Bacigalupo; M Podestà; M C Mingari; L Moretta; M T Van Lint; A Marmont
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

8.  Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation.

Authors:  G Corte; M C Mingari; A Moretta; G Damiani; L Moretta; A Bargellesi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

9.  Suppressor T-lymphocyte deficiency in Graves' disease and Hashimoto's thyroiditis.

Authors:  N Okita; V V Row; R Volpe
Journal:  J Clin Endocrinol Metab       Date:  1981-03       Impact factor: 5.958

10.  Surface antigens specifically expressed by activated T cells in humans.

Authors:  G Corte; L Moretta; G Damiani; M C Mingari; A Bargellesi
Journal:  Eur J Immunol       Date:  1981-02       Impact factor: 5.532

View more
  1 in total

1.  Incidence of T cell subset imbalance in relatives of Graves' disease patients.

Authors:  P Biassoni; G Ciprandi; S Ferrini; G Chimini; G W Canonica; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.